Metoprolol Retard Viatris (Metoprolol Succinate)

Metoprolol succinate selectively blocks β1‑adrenergic receptors in the heart, reducing the effects of adrenaline and noradrenaline. This leads to a slower heart rate, decreased contractile force, and reduced renin release from the kidneys, which together lower cardiac output and blood pressure, easing the workload on the heart.

The dosage of Metoprolol Retard is individualized by the prescribing clinician based on the patient’s condition, response, and tolerability. The prescriber determines the appropriate starting dose, titration schedule, and maintenance dose, which may differ for hypertension, angina, heart‑failure, or post‑myocardial‑infarction therapy.

Safety data for metoprolol succinate during pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers should discuss individual risk factors and consider alternative therapies when appropriate.

To order Metoprolol Retard, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Metoprolol is a cardio‑selective (β1‑selective) blocker, offering a lower risk of bronchospasm compared with non‑selective agents such as propranolol. Its extended‑release formulation provides once‑daily dosing, which can improve adherence. Compared with carvedilol, metoprolol has less α‑blocking activity, making it a preferred choice when additional vasodilation is not required.

Metoprolol Retard tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in a refrigerator or freezer.

Metoprolol Retard is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a full glass of water; it must not be split, chewed, or crushed, as this would compromise the extended‑release mechanism and alter drug exposure.

Serious adverse events include marked bradycardia, severe hypotension, heart block, and exacerbation of heart failure. Patients with asthma or chronic obstructive pulmonary disease may experience bronchospasm. Any sudden worsening of symptoms such as fainting, chest pain, or difficulty breathing should prompt immediate medical evaluation.

Metoprolol Retard is contraindicated in patients with known hypersensitivity to metoprolol or any component of the formulation, in those with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, and in individuals with cardiogenic shock or overt heart failure decompensation. Caution is also advised for patients with severe asthma or COPD.